Related Experiment Videos
Percutaneous transluminal coronary recanalization: procedure, results, and acute complications
Insights
Percutaneous transluminal coronary recanalization effectively treats acute myocardial infarction, reducing mortality and infarct size. This procedure, using streptokinase, showed low complication risks and high reperfusion rates when initiated early.
Area of Science:
- Cardiology
- Interventional Cardiology
Background:
- Acute myocardial infarction (AMI) poses significant mortality risks.
- Previous pharmacologic treatments had limitations in limiting infarct size.
- Percutaneous transluminal coronary recanalization (PTCR) emerged as a novel therapeutic approach.
Purpose of the Study:
- To evaluate the efficacy and safety of PTCR in acute myocardial infarction.
- To assess the impact of PTCR on mortality and infarct size.
- To compare PTCR with previous treatment modalities.
Main Methods:
- PTCR was performed in patients with acute myocardial infarction.
- Coronary angiography was utilized to assess vessel patency.
- Selective intracoronary infusion of streptokinase was administered.
- Mechanical recanalization was attempted in select cases.
Main Results:
- PTCR demonstrated a significant reduction in mortality (less than 1% within 6 hours).
- Effective limitation of the infarct zone was observed compared to prior treatments.
- Successful mechanical recanalization was achieved in approximately 50% of attempts.
- Intracoronary streptokinase yielded high myocardial reperfusion rates, especially when initiated early.
- Hemorrhagic complications were low despite thrombolytic administration.
Conclusions:
- PTCR is a safe and effective treatment for acute myocardial infarction.
- Early initiation of therapy is crucial for optimal reperfusion outcomes.
- While effective, residual stenosis often necessitates further interventions like bypass surgery or angioplasty.
Abstract:
Percutaneous transluminal coronary recanalization, a new therapeutic procedure used in acute myocardial infarction, offers significant reduction in mortality, as well as more effective limitation of the zone of infarction than has been possible with other pharmacologic treatment employed in the past. The risk of coronary angiography during acute myocardial infarction was surprisingly low, as was the risk of hemorrhagic complications following the intracoronary administration of relatively low doses of thrombolytic substances such as streptokinase. Mechanical recanalization was possible in about one fifth of patients and successful in approximately half of all such attempts, but complications occurred in a small percentage of attempts at this step. Coronary artery spasm was excluded as a possible cause of occlusion in almost all cases. Selective intracoronary infusion of streptokinase produced the highest degree of myocardial reperfusion, and best results were achieved when therapy was initiated shortly after thrombotic occlusion occurred. Residual stenosis of more than 75% luminal diameter narrowing was present in approximately three fourths of cases after complete thrombolysis, and the majority of patients remained appropriate candidates for coronary bypass surgery or for percutaneous transluminal coronary angioplasty (Grüntzig procedure). Although complete analysis of the efficacy of selective recanalization was difficult because it was not possible to establish a suitable control group for purposes of comparison, the mortality of less than 1% in the present group of 232 patients within the first 6 hours following myocardial reperfusion provides an encouraging result.